Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials

BACKGROUND: Hidradenitis suppurativa (HS) is a chronic skin disease characterized by inflammatory lesions that flare unpredictably. The impact of weekly adalimumab (ADAew) on HS flare is not well‐characterized. OBJECTIVE: To evaluate the impact of disease flare on health‐related quality of life (HRQ...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Zee, H.H., Longcore, M., Geng, Z., Garg, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acne, Rosacea and Hidradenitis Suppurativa
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318582/
https://www.ncbi.nlm.nih.gov/pubmed/31630445
http://dx.doi.org/10.1111/jdv.16023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318582/
https://www.ncbi.nlm.nih.gov/pubmed/31630445
http://dx.doi.org/10.1111/jdv.16023

Ejemplares similares